ZOOZ Nasdaq Misc Industrial & Commercial Machinery & Equipment Financials FY2021βFY2025
ZOOZ Strategy Ltd. had $0.2M of revenue in fiscal 2025, down 76.3% on the year before.
Hi! I read ZOOZ Strategy Ltd.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
β76.3%
No. Sales fell 76.3% last year.
Does it make a profit?
β22,505.7%
No. It lost money last year.
Does profit turn into cash?
β5,618.2%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 8
Weak. It passes 3 of 8 health tests.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days ZOOZ Strategy Ltd. did it, and the next one. Share prices often move a lot on those days.
Next results
March 26, 2027
Friday Β· in 151 days
Estimated from the same quarter last year. It will be replaced by the announced date once there is one.
See who else reports that week β| Date | Results for | Time | Source |
|---|---|---|---|
| Mar 27, 2026 | Period ended Dec 31, 2025 | Before the market opens | 20-F β |
| Mar 7, 2025 | Period ended Dec 31, 2024 | Before the market opens | 20-F β |
| Apr 30, 2024 | Period ended Dec 31, 2023 | After the market closes | 20-F β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· ZOOZ Strategy Ltd. had $0.2M of revenue in fiscal 2025, down 76.3% on the year before. Its operating margin was β21,510.5%, down 20,498.4Β pts: of every 100 in sales, about β21,511 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Margins, % of revenue
KIRA Β· ZOOZ Strategy Ltd. lost $55.6M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$13.9M in fiscal 2025, β5,618.2% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably ZOOZ Strategy Ltd. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | β | $20.6M | $6.7M | $7.5M | $27.0M |
| Interest coverage | β | β | β | β61.6x | β332.1x |
| Current ratio | β | 7.9x | 3.2x | 2.1x | 9.9x |
| Quick ratio | β | 7.2x | 2.3x | 1.6x | 9.9x |
| Total assets | β | $25.4M | $13.5M | $12.8M | $123M |
| Total liabilities | β | $4.2M | $4.3M | $6.1M | $3.4M |
| Shareholders' equity | $2.6M | $21.3M | $9.2M | $6.7M | $119M |
| Net debt (β = net cash) | β | β | β | β | β |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· ZOOZ Strategy Ltd. passes 3 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β |
| F-score | β / 3 | β / 4 | 2 / 8 | 4 / 8 | 3 / 8 |
| Accruals ratio | β | 10.7% | 2.5% | β8.1% | β61.7% |
| Altman Z'' | β | 3.80 | β11.83 | β16.34 | 32.65 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | β$0.1M | $0.7M | $0.8M | $1.0M | $0.2M |
| Net interest income | β$0.0M | $0.4M | $0.5M | β$0.3M | β$2.3M |
| Noninterest income | β$0.0M | $0.3M | $0.2M | β$0.4M | β$2.5M |
| Gross profit | β | β$0.2M | β$1.1M | β$0.5M | β$2.9M |
| Research and development | $1.5M | $4.2M | $5.2M | $5.1M | $3.7M |
| Operating income | β$4.5M | β$8.2M | β$12.2M | β$10.5M | β$53.1M |
| Interest expense | β | β | β | $0.2M | $0.2M |
| Pretax income | β$4.6M | β$7.8M | β$11.8M | β | β |
| Net income | β$4.6M | β$7.8M | β$11.8M | β$11.0M | β$55.6M |
| Diluted EPS | β$2.27 | β$1.51 | β$1.99 | β$1.09 | β$0.94 |
| Diluted shares | 0.00B | 0.01B | 0.00B | 0.00B | 0.00B |
| Cash flow | |||||
| Cash from operations | β$6.1M | β$10.5M | β$12.2M | β$9.9M | β$13.8M |
| Capital expenditure | $0.3M | $0.5M | $1.4M | $0.1M | $0.1M |
| Free cash flow | β$6.4M | β$11.0M | β$13.6M | β$10.0M | β$13.9M |
| Depreciation and amortization | $0.0M | $0.1M | $0.2M | $0.4M | $0.4M |
| Stock-based compensation | β$1.3M | β$1.8M | β$0.2M | $0.4M | $6.7M |
| Balance sheet | |||||
| Cash and short-term investments | β | $20.6M | $6.7M | $7.5M | $27.0M |
| Current assets | β | $22.9M | $10.3M | $10.7M | $28.9M |
| Current liabilities | β | $2.9M | $3.3M | $5.2M | $2.9M |
| Inventory | β | $1.8M | $2.8M | $2.3M | β |
| Property and equipment, net | β | $0.7M | $1.6M | $0.9M | $0.3M |
| Total assets | β | $25.4M | $13.5M | $12.8M | $123M |
| Total liabilities | β | $4.2M | $4.3M | $6.1M | $3.4M |
| Shareholders' equity | $2.6M | $21.3M | $9.2M | $6.7M | $119M |
| Margins | |||||
| Gross margin | β | β27.1% | β144.6% | β46.7% | β1,159.5% |
| Operating margin | 5,893.5% | β1,250.3% | β1,598.3% | β1,012.1% | β21,510.5% |
| EBITDA margin | 5,836.4% | β1,230.3% | β1,567.0% | β976.2% | β21,363.2% |
| Net margin | 5,949.4% | β1,192.8% | β1,538.6% | β1,055.7% | β22,505.7% |
| FCF margin | 8,289.6% | β1,684.0% | β1,779.7% | β960.1% | β5,618.2% |
| Net interest share of revenue | 55.8% | 57.5% | 59.7% | β27.2% | β930.4% |
| Returns | |||||
| Return on capital employed | β | β36.4% | β119.4% | β137.8% | β44.4% |
| Return on equity | β173.7% | β65.5% | β77.2% | β138.2% | β88.3% |
| Return on assets | β | β30.8% | β60.4% | β83.5% | β82.1% |
| Return on tangible equity | β173.7% | β36.8% | β127.9% | β163.6% | β46.6% |
| Growth | |||||
| Revenue growth | β | β | 16.5% | 36.3% | β76.3% |
| Share count change | β | 155.7% | β99.9% | 71.2% | 487.1% |
| Financial health | |||||
| Interest coverage | β | β | β | β61.6x | β332.1x |
| Current ratio | β | 7.9x | 3.2x | 2.1x | 9.9x |
| Quick ratio | β | 7.2x | 2.3x | 1.6x | 9.9x |
| Capital allocation | |||||
| Capex / revenue | β387.0% | 76.2% | 178.7% | 6.4% | 37.7% |
| Stock comp / revenue | 1,707.8% | β266.9% | β28.7% | 35.4% | 2,713.0% |
| Quality scores | |||||
| Piotroski F-score | β | β | 2.0 | 4.0 | 3.0 |
| Altman Z'' | β | 3.8 | β11.8 | β16.3 | 32.6 |
| Accruals ratio | β | 10.7% | 2.5% | β8.1% | β61.7% |
Source: SEC EDGAR XBRL filings (CIK 0001992818). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
